Skip to content
10-Q/A

Quarterly Report

GT Biopharma, Inc. GTBP

0001493152-26-009126

← back to feed
Filed
Mar 6, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 10.64M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.03M sh
Shares Diluted Q3 2025 · Sep 30, 2024 2.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.78M sh
Dividends Paid Q3 2025 · Sep 30, 2025 $85K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$8.89M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$10.44M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.53M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.95M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3M
Stockholders Equity restated Q3 2025 · Jun 30, 2025 −$25.88M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$1.67M
Stockholders Equity Q3 2025 · Sep 30, 2024 $2.1M
Stockholders Equity Q3 2025 · Jun 30, 2024 $5.51M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.48M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.32M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.9M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.32M
Current Assets Q3 2025 · Sep 30, 2025 $4.32M
Current Assets Q3 2025 · Dec 31, 2024 $4.23M
Total Assets Q3 2025 · Sep 30, 2025 $4.32M
Eps Diluted restated Q3 2025 · Sep 30, 2025 $1.04
Eps Diluted restated Q3 2025 · Sep 30, 2025 −$8.90
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.53
Eps Diluted Q3 2025 · Sep 30, 2024 −$5.28
Eps Basic restated Q3 2025 · Sep 30, 2025 $1.04
Eps Basic restated Q3 2025 · Sep 30, 2025 −$8.90
Eps Basic Q3 2025 · Sep 30, 2024 −$1.53
Eps Basic Q3 2025 · Sep 30, 2024 −$5.28
Sga Expense Q3 2025 · Sep 30, 2025 $2.75M
Sga Expense Q3 2025 · Sep 30, 2025 $4.73M
Sga Expense Q3 2025 · Sep 30, 2024 $2.3M
Sga Expense Q3 2025 · Sep 30, 2024 $6.73M
Rd Expense Q3 2025 · Sep 30, 2025 $634K
Rd Expense Q3 2025 · Sep 30, 2025 $2.1M
Rd Expense Q3 2025 · Sep 30, 2024 $1.31M
Rd Expense Q3 2025 · Sep 30, 2024 $3.87M
Net Income restated Q3 2025 · Sep 30, 2025 $8.3M
Net Income restated Q3 2025 · Sep 30, 2025 −$22.65M
Net Income Q3 2025 · Sep 30, 2024 −$3.41M
Net Income Q3 2025 · Sep 30, 2024 −$9.39M
Operating Income Q3 2025 · Sep 30, 2025 −$3.38M
Operating Income Q3 2025 · Sep 30, 2025 −$6.83M
Operating Income Q3 2025 · Sep 30, 2024 −$3.6M
Operating Income Q3 2025 · Sep 30, 2024 −$10.6M